


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:08Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405605" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405605</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" id="pai70191" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Allergy Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Allergy Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">PAI</journal-id><journal-title-group><journal-title>Pediatric Allergy and Immunology</journal-title></journal-title-group><issn pub-type="ppub">0905-6157</issn><issn pub-type="epub">1399-3038</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405605</article-id><article-id pub-id-type="pmcid-ver">PMC12405605.1</article-id><article-id pub-id-type="pmcaid">12405605</article-id><article-id pub-id-type="pmcaiid">12405605</article-id><article-id pub-id-type="pmid">40898383</article-id><article-id pub-id-type="doi">10.1111/pai.70191</article-id><article-id pub-id-type="publisher-id">PAI70191</article-id><article-id pub-id-type="other">PAI-25-STR-0276.R2</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Systematic Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Control of Allergic Rhinitis and Asthma Test for Children (<styled-content style="fixed-case" toggle="no">CARATkids</styled-content>): A systematic review and meta&#8208;analysis of its measurement properties</article-title><alt-title alt-title-type="left-running-head">El Didi et&#160;al.</alt-title></title-group><contrib-group><contrib id="pai70191-cr-0001" contrib-type="author"><name name-style="western"><surname>El Didi</surname><given-names initials="HS">Hadla Sami</given-names></name><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0002" contrib-type="author"><name name-style="western"><surname>Pereira</surname><given-names initials="AM">Ana Margarida</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5468-0932</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0003" contrib-type="author"><name name-style="western"><surname>J&#225;come</surname><given-names initials="C">Cristina</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1151-8791</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0004" contrib-type="author"><name name-style="western"><surname>Amaral</surname><given-names initials="R">Rita</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0233-830X</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="pai70191-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="pai70191-cr-0005" contrib-type="author"><name name-style="western"><surname>Wandalsen</surname><given-names initials="GF">Gustavo F.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2173-4380</contrib-id><xref rid="pai70191-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pai70191-cr-0006" contrib-type="author"><name name-style="western"><surname>Emons</surname><given-names initials="J">Joyce</given-names></name><xref rid="pai70191-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="pai70191-cr-0007" contrib-type="author"><name name-style="western"><surname>La Grutta</surname><given-names initials="S">Stefania</given-names></name><xref rid="pai70191-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="pai70191-cr-0008" contrib-type="author"><name name-style="western"><surname>Cilluffo</surname><given-names initials="G">Giovanna</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4305-3981</contrib-id><xref rid="pai70191-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="pai70191-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="pai70191-cr-0009" contrib-type="author"><name name-style="western"><surname>Batmaz</surname><given-names initials="SB">Sehra Birg&#252;l</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1913-5346</contrib-id><xref rid="pai70191-aff-0008" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib id="pai70191-cr-0010" contrib-type="author"><name name-style="western"><surname>Linhares</surname><given-names initials="D">Daniela</given-names></name><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0011" contrib-type="author"><name name-style="western"><surname>Sole</surname><given-names initials="D">Dirceu</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3579-0861</contrib-id><xref rid="pai70191-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="pai70191-cr-0012" contrib-type="author"><name name-style="western"><surname>Sousa&#8208;Pinto</surname><given-names initials="B">Bernardo</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1277-3401</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0013" contrib-type="author"><name name-style="western"><surname>Fonseca</surname><given-names initials="JA">Jo&#227;o Almeida</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0887-8796</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="pai70191-cr-0014" contrib-type="author" corresp="yes"><name name-style="western"><surname>Vieira</surname><given-names initials="RJ">Rafael Jos&#233;</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1834-3055</contrib-id><xref rid="pai70191-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>rafaelvieira@med.up.pt</email></address></contrib></contrib-group><aff id="pai70191-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, RISE&#8208;Health</named-content>
<institution>University of Porto</institution>
<city>Porto</city>
<country country="PT">Portugal</country>
</aff><aff id="pai70191-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">School of Health</named-content>
<institution>Polytechnic of Porto</institution>
<city>Porto</city>
<country country="PT">Portugal</country>
</aff><aff id="pai70191-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Escola Paulista de Medicina</named-content>
<institution>Universidade Federal de S&#227;o Paulo</institution>
<city>S&#227;o Paulo</city>
<country country="BR">Brazil</country>
</aff><aff id="pai70191-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Division of Pediatric Respiratory Medicine and Allergology, Department of Pediatrics</named-content>
<institution>Erasmus MC University Medical Center</institution>
<city>Rotterdam</city>
<country country="NL">The Netherlands</country>
</aff><aff id="pai70191-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Institute of Translational Pharmacology</named-content>
<institution>National Research Council</institution>
<city>Palermo</city>
<country country="IT">Italy</country>
</aff><aff id="pai70191-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Earth and Marine Sciences, DiSTeM</named-content>
<institution>University of Palermo</institution>
<city>Palermo</city>
<country country="IT">Italy</country>
</aff><aff id="pai70191-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">CoNISMa</named-content>
<institution>National Inter&#8208;University Consortium for Marine Sciences</institution>
<city>Rome</city>
<country country="IT">Italy</country>
</aff><aff id="pai70191-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Department of Pediatric Allergy and Clinical Immunology</named-content>
<institution>Tokat State Hospital</institution>
<city>Tokat</city>
<country country="TR">Turkey</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Rafael Jos&#233; Vieira, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), RISE&#8208;Health, Faculty of Medicine of the University of Porto, Rua Dr. Pl&#225;cido da Costa s/n, Porto 4200&#8208;450, Portugal.<break/>
Email: <email>rafaelvieira@med.up.pt</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2025</year></pub-date><volume>36</volume><issue seq="23">9</issue><issue-id pub-id-type="pmc-issue-id">496084</issue-id><issue-id pub-id-type="doi">10.1111/pai.v36.9</issue-id><elocation-id>e70191</elocation-id><history><date date-type="rev-recd"><day>19</day><month>8</month><year>2025</year></date><date date-type="received"><day>21</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Pediatric Allergy and Immunology</italic> published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="PAI-36-e70191.pdf"/><self-uri content-type="pdf" xlink:href="file:PAI-36-e70191.pdf"/><abstract><title>Abstract</title><p>Control of Allergic Rhinitis and Asthma Test for Children (CARATkids) is the first patient&#8208;reported outcome measure (PROM) designed to assess both allergic rhinitis and asthma simultaneously in children aged 6 to 12&#8201;years. CARATkids has been validated in several languages and countries, highlighting the need for a review of its psychometric properties. This study aims to evaluate the measurement properties of CARATkids. This systematic review follows PRISMA and COSMIN guidelines. A systematic search was performed across three databases (Ovid/MEDLINE, Web of Science, and Scopus in October 2023, updated in June 2025). We included studies focused on the development, cultural adaptation, or validation of CARATkids, as well as studies comparing CARATkids with other PROMs. We evaluated the quality of CARATkids development, the methodological quality of primary studies, the overall rating, and the certainty of evidence for each CARATkids measurement property and performed a meta&#8208;analysis of its measurement properties. Our search retrieved 193 results. We included nine studies. CARATkids displayed sufficient content validity. Regarding internal consistency, we found a meta&#8208;analytical Cronbach alpha of 0.81 (95% CI&#8201;=&#8201;0.79; 0.83). CARATkids displayed sufficient reliability (meta&#8208;analytical intraclass correlation coefficient 0.86 [95% CI&#8201;=&#8201;0.61; 0.96]). The minimal clinically important difference was 2.76. Construct validity had sufficient evidence for most correlations, with absolute meta&#8208;analytical Spearman coefficients from 0.37 to 0.71. Responsiveness showed strong correlations between CARATkids and most outcome measurement instruments. These findings support CARATkids as a suitable tool for assessing asthma and allergic rhinitis in children aged 6 to 12&#8201;years who present both conditions simultaneously.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="pai70191-kwd-0001">Allergic rhinitis</kwd><kwd id="pai70191-kwd-0002">asthma</kwd><kwd id="pai70191-kwd-0003">CARATkids</kwd><kwd id="pai70191-kwd-0004">COSMIN</kwd><kwd id="pai70191-kwd-0005">patient&#8208;reported outcomes</kwd><kwd id="pai70191-kwd-0006">psychometrics</kwd></kwd-group><counts><fig-count count="2"/><table-count count="3"/><page-count count="10"/><word-count count="6100"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.2 mode:remove_FC converted:02.09.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="PAI70191-cit-2001"><string-name name-style="western"><surname>El Didi</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>J&#225;come</surname><given-names>C</given-names></string-name>, et al. <article-title>Control of Allergic Rhinitis and Asthma Test for Children (<styled-content style="fixed-case" toggle="no">CARATkids</styled-content>): A systematic review and meta&#8208;analysis of its measurement properties</article-title>. <source>Pediatr Allergy Immunol</source>. <year>2025</year>;<volume>36</volume>:<elocation-id>e70191</elocation-id>. doi:<pub-id pub-id-type="doi">10.1111/pai.70191</pub-id><pub-id pub-id-type="pmid">40898383</pub-id><pub-id pub-id-type="pmcid">PMC12405605</pub-id></mixed-citation>
</p><fn-group id="pai70191-ntgp-0001"><fn id="pai70191-note-0001"><p>
<bold>Editor:</bold> Jon Genuneit</p></fn></fn-group></notes></front><body id="pai70191-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="pai70191-blkfxd-0001" orientation="portrait"><caption><title>Key message</title></caption><p>CARATkids is a reliable and valid patient&#8208;reported outcome measure for assessing asthma and allergic rhinitis control in children, supporting its clinical use for monitoring and guiding treatment decisions.</p></boxed-text>
</p><sec id="pai70191-sec-0003"><label>1</label><title>INTRODUCTION</title><p>Patient&#8208;reported outcome measures (PROMs) quantify the impact of health conditions and treatments from the patients' perspective.<xref rid="pai70191-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> They provide insights into several aspects of disease, including symptom burden, well&#8208;being, and quality of life,<xref rid="pai70191-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> informing clinical decisions and resource planning.<xref rid="pai70191-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>In pediatric care, the importance of understanding patients' perceptions of their diseases and healthcare experience is increasingly recognized.<xref rid="pai70191-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> PROMs empower children to actively participate in managing their conditions.<xref rid="pai70191-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> This is especially relevant in asthma and allergic rhinitis, as these chronic conditions present with variable symptoms and triggers, so that PROMs may help tailor treatment and improve long&#8208;term management.</p><p>There are several PROMs available to assess the control of asthma or allergic rhinitis in children, such as the Childhood Asthma Control Test (cACT),<xref rid="pai70191-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> the Pediatric Quality of Life Asthma Questionnaire,<xref rid="pai70191-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="pai70191-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> the Asthma Therapy Assessment Questionnaire for Children (ATAQ&#8208;Children),<xref rid="pai70191-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> the Visual Analogue Scale (VAS) for asthma and allergic rhinitis,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> the Total Nasal Symptom Score (TNSS),<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> and the Control of Allergic Rhinitis and Asthma Test for Children (CARATkids).<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> However, only the latter assesses both conditions simultaneously. The Allergic Rhinitis and Its Impact on Asthma (ARIA) group recommends that both conditions be assessed using a single tool, since allergic rhinitis is frequently associated with asthma, representing both a risk factor and a contributor to poor asthma control.<xref rid="pai70191-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> To the best of our knowledge, CARATkids is the only PROM assessing the control of both asthma and allergic rhinitis in children. Developed from the Control of Allergic Rhinitis and Asthma Test (CARAT) questionnaire for adults,<xref rid="pai70191-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> the pediatric version consists of 13 questions (8 for children and 5 for caregivers).<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Its score ranges from 0 (best control) to 13 (worst control) points, with scores of 3 or lower indicating good disease control, and scores of 6 or higher identifying uncontrolled disease.<xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p><p>Besides Portugal,<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> where this tool was created, CARATkids has already been applied and validated in several languages and countries, such as Brazil,<xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Turkey,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Italy,<xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> and the Netherlands.<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Its widespread use prompts the need for a systematic assessment of its measurement (psychometric) properties. Therefore, the purpose of this systematic review was to objectively evaluate the measurement properties of CARATkids using the COnsensus&#8208;based Standards for the selection of health status Measurement Instruments (COSMIN) guidelines for systematic reviews of PROMs.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="pai70191-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p></sec><sec sec-type="methods" id="pai70191-sec-0004"><label>2</label><title>METHODS</title><sec id="pai70191-sec-0005"><label>2.1</label><title>Study design</title><p>This systematic review was reported according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta&#8208;Analyses (PRISMA)<xref rid="pai70191-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> and the recommendations of the COSMIN methodology for systematic reviews of PROMs.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="pai70191-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p></sec><sec id="pai70191-sec-0006"><label>2.2</label><title>Selection criteria</title><p>We included original studies that (i) involved children aged 6 to 12&#8201;years with asthma and/or allergic rhinitis, corresponding to the target population for the application of the PROM, and (ii) focused on its development, cultural adaptation, or validation, or which employed the CARATkids alongside another PROM to assess allergic rhinitis and/or asthma control. Conference abstracts were excluded per COSMIN recommendations. No limitations were applied concerning the publication date or language.</p></sec><sec id="pai70191-sec-0007"><label>2.3</label><title>Search strategy</title><p>We searched Ovid/MEDLINE, Web of Science, and Scopus in October 2023, with an update in June 2025. The search strategy was created by search experts from the Porto Associate Center of Cochrane Portugal and the Portuguese GRADE network (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S1</xref>). We also screened reference lists and manually searched Google Scholar for additional relevant studies (including relevant gray literature).</p></sec><sec id="pai70191-sec-0008"><label>2.4</label><title>Study selection</title><p>After removing duplicates, two authors independently evaluated articles' titles and abstracts. Reports that were not excluded were then independently assessed in their full content. When access to any of the publications was not possible by other means, efforts were made to contact the original investigators. Lack of access to publications did not lead to the exclusion of any studies. Conflicts between the authors were resolved by consensus.</p></sec><sec id="pai70191-sec-0009"><label>2.5</label><title>Data extraction</title><p>Two authors independently extracted data from each included primary study using a custom&#8208;built form (Data&#160;<xref rid="pai70191-supitem-0002" ref-type="supplementary-material">S2</xref>), including sample size, age and gender distribution of participants, prevalence of patients with allergic rhinitis and/or asthma, country and language of questionnaire administration. Additionally, we extracted data on the measurement properties reported for CARATkids in each primary study.</p></sec><sec id="pai70191-sec-0010"><label>2.6</label><title>Quality assessment</title><p>Quality assessment followed the COSMIN methodology for assessing the content validity of PROMs&#8212;User Manual<xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> and the COSMIN guideline for systematic reviews of PROM.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Two authors independently assessed (i) the quality of the PROM development, (ii) the methodological quality of primary studies, (iii) the overall rating, and (iv) the certainty of evidence for each measurement property (Figure&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><p>The development of CARATkids was assessed based on the PROM design and cognitive pilot testing, as described in the COSMIN methodology for assessing the content validity of PROMs&#8212;User Manual.<xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Each item was classified into &#8220;Very Good,&#8221; &#8220;Adequate,&#8221; &#8220;Doubtful,&#8221; or &#8220;Inadequate.&#8221; For comparison, the same assessment was performed for three other pediatric asthma PROMs, namely cACT, CAQ&#8208;B, and TRACK.</p><p>The methodological quality of primary studies (including those concerning PROM development) was assessed using the COSMIN risk of bias checklist,<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> with ratings from &#8220;Very Good&#8221; to &#8220;Inadequate.&#8221; For each measurement property, the rating was based on the lowest graded item within each measurement property.</p><p>The overall rating concerns the quantitative results of each measurement property compared with pre&#8208;established criteria for good measurement properties (typically predefined cut&#8208;offs).<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> The results for each measurement property were rated as &#8220;Sufficient (+),&#8221; &#8220;Insufficient (&#8722;),&#8221; or &#8220;Indeterminate (?),&#8221; based on their alignment with these criteria. Assessed measurement properties included content validity, internal consistency, reliability, construct validity, and responsiveness. None of the included studies assessed the structural validity of CARATkids. Content validity was assessed using five relevance criteria, one for comprehensiveness, and two for comprehensibility.<xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> The remaining properties were assessed through comparison with pre&#8208;established criteria for good measurement properties (typically predefined cut&#8208;offs),<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> available in Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S2</xref>. The results for each measurement property were rated as &#8220;Sufficient (+),&#8221; &#8220;Insufficient (&#8722;),&#8221; or &#8220;Indeterminate (?),&#8221; based on their alignment with these criteria.</p><p>Finally, the certainty of evidence was rated as high, moderate, low, or very low based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, which considers the methodological quality of the studies, inconsistency, imprecision, and indirectness.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="pai70191-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="pai70191-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</p></sec><sec id="pai70191-sec-0011"><label>2.7</label><title>Data analysis</title><p>We conducted meta&#8208;analyses of Cronbach's alpha (internal consistency), intraclass correlation coefficients (reliability), and Spearman correlation coefficients (construct validity and responsiveness). Other properties, such as measurement error, were not analyzed due to insufficient data.</p><p>We applied a random&#8208;effects model, using the restricted maximum likelihood method. Whenever studies did not report precision measures, variances were estimated following methods reported elsewhere.<xref rid="pai70191-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Therefore, for performing meta&#8208;analysis of Spearman correlation coefficients and ICCs, coefficients were firstly transformed according to the formula <mml:math id="jats-math-1" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0.5</mml:mn><mml:mo>&#215;</mml:mo><mml:mi>ln</mml:mi><mml:mspace width="0.25em"/><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mtext>correlation</mml:mtext><mml:mspace width="0.5em"/><mml:mtext>coefficient</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#8722;</mml:mo><mml:mtext>correlation</mml:mtext><mml:mspace width="0.5em"/><mml:mtext>coefficient</mml:mtext></mml:mrow></mml:mfrac></mml:mfenced></mml:mrow></mml:mrow></mml:math>, with their variances being estimated by <mml:math id="jats-math-2" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#8722;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mrow></mml:math>
<xref rid="pai70191-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>; meta&#8208;analytical results were then back transformed to the natural scale. For Cronbach alphas, variances were estimated based on computed confidence interval limits.<xref rid="pai70191-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</p><p>Heterogeneity was assessed using the <italic toggle="yes">I</italic>
<sup>2</sup> statistic and the <italic toggle="yes">p</italic>&#8208;value from the Q&#8208;Cochran statistic, with <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;&gt;&#8201;50% and <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.10 deemed to represent substantial and significant heterogeneity. In the presence of substantial heterogeneity, leave&#8208;one&#8208;out sensitivity analyses were&#160;performed.</p><p>All analyses were performed using R (version 4.4.1; R Core Team 2024).</p></sec></sec><sec sec-type="results" id="pai70191-sec-0012"><label>3</label><title>RESULTS</title><sec id="pai70191-sec-0013"><label>3.1</label><title>Studies selection</title><p>Our search yielded a total of 193 results (Figure&#160;<xref rid="pai70191-fig-0001" ref-type="fig">1</xref>). After removing duplicate entries, 128 unique studies remained for initial screening. Of those, 15 studies were evaluated based on their full texts. In total, nine original studies (10 reports, since the development study was published in two reports<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>) were included in the systematic review (Table&#160;<xref rid="pai70191-tbl-0001" ref-type="table">1</xref>).<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="pai70191-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="pai70191-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="pai70191-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Preferred Reporting Items for Systematic Reviews and Meta&#8208;Analyses (PRISMA) flow diagram illustrating the studies' selection process. Records refer to titles and abstracts identified through database or other searches; reports are full&#8208;text articles or documents retrieved for detailed evaluation; studies are unique investigations (e.g., experimental or observational studies) that may be published/described in one or more reports.</p></caption><graphic position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="PAI-36-e70191-g001.jpg"/></fig><table-wrap position="float" id="pai70191-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Characteristics of the included studies (<italic toggle="no">n</italic>&#8201;=&#8201;771 participants).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Age mean (SD)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Females <italic toggle="yes">N</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Country</th><th align="left" valign="bottom" rowspan="1" colspan="1">Language</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Borrego 2013<xref rid="pai70191-note-0003" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="char" char="." valign="top" rowspan="1" colspan="1">29</td><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">11 (37.9)</td><td align="left" valign="top" rowspan="1" colspan="1">Portugal</td><td align="left" valign="top" rowspan="1" colspan="1">European Portuguese</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Linhares 2014</td><td align="char" char="." valign="top" rowspan="1" colspan="1">113<xref rid="pai70191-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">8.75 (1.86)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">44 (38.9)</td><td align="left" valign="top" rowspan="1" colspan="1">Portugal</td><td align="left" valign="top" rowspan="1" colspan="1">European Portuguese</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resende 2015</td><td align="char" char="." valign="top" rowspan="1" colspan="1">47</td><td align="left" valign="top" rowspan="1" colspan="1">9.34 (2.34)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">13 (27.7)</td><td align="left" valign="top" rowspan="1" colspan="1">Portugal</td><td align="left" valign="top" rowspan="1" colspan="1">European Portuguese</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Emons 2017</td><td align="char" char="." valign="top" rowspan="1" colspan="1">55</td><td align="left" valign="top" rowspan="1" colspan="1">8.6 (1.69)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29 (52.7)</td><td align="left" valign="top" rowspan="1" colspan="1">Netherlands</td><td align="left" valign="top" rowspan="1" colspan="1">Dutch</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amaral 2017</td><td align="char" char="." valign="top" rowspan="1" colspan="1">102</td><td align="left" valign="top" rowspan="1" colspan="1">9.1 (1.8)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">55 (53.9)</td><td align="left" valign="top" rowspan="1" colspan="1">Brazil</td><td align="left" valign="top" rowspan="1" colspan="1">Brazilian Portuguese</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Batmaz 2018</td><td align="char" char="." valign="top" rowspan="1" colspan="1">174</td><td align="left" valign="top" rowspan="1" colspan="1">8.72 (2.15)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">78 (44.8)</td><td align="left" valign="top" rowspan="1" colspan="1">Turkey</td><td align="left" valign="top" rowspan="1" colspan="1">Turkish</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cilluffo 2019</td><td align="char" char="." valign="top" rowspan="1" colspan="1">112</td><td align="left" valign="top" rowspan="1" colspan="1">8.3 (1.63)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">37 (33.0)</td><td align="left" valign="top" rowspan="1" colspan="1">Italy</td><td align="left" valign="top" rowspan="1" colspan="1">Italian</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tosca 2020</td><td align="char" char="." valign="top" rowspan="1" colspan="1">88</td><td align="left" valign="top" rowspan="1" colspan="1">9.9</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">30 (34.1)</td><td align="left" valign="top" rowspan="1" colspan="1">Italy</td><td align="left" valign="top" rowspan="1" colspan="1">Italian</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mata 2025</td><td align="char" char="." valign="top" rowspan="1" colspan="1">51</td><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">22 (43.1)</td><td align="left" valign="top" rowspan="1" colspan="1">Portugal</td><td align="left" valign="top" rowspan="1" colspan="1">European Portuguese</td></tr></tbody></table><table-wrap-foot id="pai70191-ntgp-0002"><fn id="pai70191-note-0002"><p>Abbreviation: SD, standard deviation.</p></fn><fn id="pai70191-note-0003"><label>
<sup>a</sup>
</label><p>Original CARATkids development study.</p></fn><fn id="pai70191-note-0004"><label>
<sup>b</sup>
</label><p>101 patients filled out the CARATkids questionnaire in both visits.</p></fn></table-wrap-foot></table-wrap></sec><sec id="pai70191-sec-0014"><label>3.2</label><title>Characteristics of included studies</title><p>Table&#160;<xref rid="pai70191-tbl-0001" ref-type="table">1</xref> provides a summary of the included studies. Five studies (published in six reports) employed the Portuguese version of CARATkids,<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="pai70191-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>, <xref rid="pai70191-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> including one adapted to Brazilian Portuguese.<xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Two studies used the Italian version,<xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> one study applied the Dutch version<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and another used the Turkish version.<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> One study compared an electronic Portuguese version of CARATkids against the paper version.<xref rid="pai70191-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> In total, 771 children were assessed, with a mean age ranging from 8 to 9.9&#8201;years old. One Italian study<xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> and the Dutch study<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> also included adolescents, but only the Italian study reported results for each subgroup. Aside from the Dutch and one of the Portuguese studies,<xref rid="pai70191-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> participants in all studies presented both AR and asthma.</p></sec><sec id="pai70191-sec-0015"><label>3.3</label><title>Methodological quality of primary studies</title><p>The methodological quality ratings for each psychometric property varied within each study. Most of the properties were rated as either &#8220;Very good&#8221; or &#8220;Adequate,&#8221; suggesting a low overall risk of bias (Table&#160;<xref rid="pai70191-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="pai70191-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Methodological quality of studies on the measurement properties of the Control of Allergic Rhinitis and Asthma Test for Children (CARATkids).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Structural validity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Internal consistency</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reliability</th><th align="left" valign="bottom" rowspan="1" colspan="1">Measurement error</th><th align="left" valign="bottom" rowspan="1" colspan="1">Construct validity</th><th align="left" valign="bottom" rowspan="1" colspan="1">Responsiveness</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Linhares 2014</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resende 2015</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Emons 2016</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amaral 2017</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Batmaz 2018</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cillufo 2019</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">A</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tosca 2020</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">A</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mata 2025</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">V</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall risk of bias</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">Low</td></tr></tbody></table><table-wrap-foot id="pai70191-ntgp-0003"><fn id="pai70191-note-0005"><p>
<italic toggle="yes">Note</italic>: A&#8201;=&#8201;adequate; V&#8201;=&#8201;very good.</p></fn></table-wrap-foot></table-wrap><p>The quality of PROM development is presented in Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S3</xref>. This assessment was based on the development study (published in two reports<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>). Regarding general design requirements, most criteria were rated as &#8220;Very good,&#8221; except for sample representativeness, which was rated as &#8220;Inadequate.&#8221; That is because the development was based on consensus meetings with experts, with no explicit involvement of children or their caregivers in this phase. Consequently, the design of CARATkids was rated &#8220;Inadequate,&#8221; reflecting the lowest assigned rating. For the cognitive interview study, sample representativeness was considered &#8220;Very good.&#8221; Comprehensibility was deemed &#8220;Doubtful,&#8221; since meetings were recorded but not transcribed verbatim. As a comparison, we also assessed the quality of the development of cACT, CAQ&#8208;B, and TRACK. The development of these three PROMs was deemed &#8220;Inadequate&#8221; as well (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S4</xref>).</p></sec><sec id="pai70191-sec-0016"><label>3.4</label><title>Measurement properties of <styled-content style="fixed-case" toggle="no">CARATkids</styled-content>
</title><p>All measurement properties were assessed at least once, except for structural validity, cross&#8208;cultural validity, and criterion validity. For the latter, comparisons between CARATkids and other PROMs were interpreted as evidence for construct validity (and not criterion validity), in accordance with COSMIN guidelines.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Overall, we found evidence for sufficient content validity, reliability, construct validity, and responsiveness. Internal consistency was rated indeterminate since structural validity was not assessed by any study (Tables&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S5</xref> and <xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>). Meta&#8208;analytical details can be seen in Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref> and are summarized in Figure&#160;<xref rid="pai70191-fig-0002" ref-type="fig">2</xref>.</p><table-wrap position="float" id="pai70191-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Meta&#8208;analytical results for the consistency, reliability, construct validity, and responsiveness of the Control of Allergic Rhinitis and Asthma Test for Children (CARATkids).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> primary studies</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> participants</th><th align="left" valign="bottom" rowspan="1" colspan="1">Meta&#8208;analytical result (95% CI) [<italic toggle="yes">I</italic>
<sup>2</sup>; <italic toggle="yes">Q</italic>&#8208;Cochran <italic toggle="yes">p</italic>&#8208;value]</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Internal consistency&#8212;Cronbach alpha</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">495</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.81 (0.79; 0.83) [23.6%; .320]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reliability&#8212;ICC</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">439</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.86 (0.61; 0.96) [97.4%; &lt;.001]</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Construct validity</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS global</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">55</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.40; 0.74) [&#8722;]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS nose</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">432</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.49 (0.40; 0.57) [37.7%; .217]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS asthma</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">432</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.51; 0.68) [57.5%; .070]<xref rid="pai70191-note-0007" ref-type="table-fn">
<sup>a</sup>
</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with cACT</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">544</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&#8722;0.71 (&#8722;0.76; &#8722;0.64) [67.7%; .020]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with TNSS</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">276</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.69 (0.47; 0.83) [93.0%; &lt;.001]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with EQ&#8208;5D&#8208;Y VAS</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">47</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&#8722;0.37 (&#8722;0.59; &#8722;0.10) [&#8722;]</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Responsiveness</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS global</td><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="char" char="." valign="top" rowspan="1" colspan="1">55</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.40; 0.74) [&#8722;]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS nose</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">432</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.53 (0.45; 0.60) [0%; .73]</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with VAS asthma</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="char" char="." valign="top" rowspan="1" colspan="1">432</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.49 (0.36; 0.61) [55.9%; .076]<xref rid="pai70191-note-0008" ref-type="table-fn">
<sup>b</sup>
</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with cACT</td><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="char" char="." valign="top" rowspan="1" colspan="1">544</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">&#8722;0.58 (&#8722;0.72; &#8722;0.40) [83.5%; &lt;.001]<xref rid="pai70191-note-0009" ref-type="table-fn">
<sup>c</sup>
</xref>
</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Correlation with TNSS</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="char" char="." valign="top" rowspan="1" colspan="1">276</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">0.58 (0.44; 0.70) [48.6%; .163]</td></tr></tbody></table><table-wrap-foot id="pai70191-ntgp-0004"><fn id="pai70191-note-0006"><p>Abbreviations: cACT, childhood asthma control test; CI, confidence interval; ICC, intraclass correlation coefficient; TNSS, Total Nasal Symptom Score; VAS, visual analogue scale.</p></fn><fn id="pai70191-note-0007"><label>
<sup>a</sup>
</label><p>In leave&#8208;one&#8208;out sensitivity analysis, excluding Batmaz 2018: 0.56 (95% CI&#8201;=&#8201;0.49; 0.63); <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;4.9%.</p></fn><fn id="pai70191-note-0008"><label>
<sup>b</sup>
</label><p>In leave&#8208;one&#8208;out sensitivity analysis, excluding Amaral 2017: 0.56 (95% CI&#8201;=&#8201;0.47; 0.63); <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;0%.</p></fn><fn id="pai70191-note-0009"><label>
<sup>c</sup>
</label><p>In leave&#8208;one&#8208;out sensitivity analysis, excluding Batmaz 2018: &#8722;0.51 (95% CI&#8201;=&#8201;&#8722;0.59; &#8722;0.41); <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;0%.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="pai70191-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Main meta&#8208;analytical results on the properties of the Control of Allergic Rhinitis and Asthma Test for Children (CARATkids). Light green areas indicate the range of good results according to the COSMIN guidelines, that is, values that meet the criteria for sufficient measurement properties: Cronbach's alpha &#8805;0.70 for internal consistency, intraclass correlation coefficient (ICC) &#8805;0.70 for reliability, and Spearman's correlation coefficient &#8805;0.70 for similar constructs or &#8805;0.50 for related but dissimilar constructs in the evaluation of construct validity and responsiveness. cACT, Childhood Asthma Control Test; CI, confidence interval; TNSS, Total Nasal Symptom Score; VAS, visual analogue scale.</p></caption><graphic position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="PAI-36-e70191-g002.jpg"/></fig><sec id="pai70191-sec-0017"><label>3.4.1</label><title>Content validity</title><p>The assessment of the content validity was based on the development study<xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> and our own assessment (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S5</xref>). We rated content validity as &#8220;Sufficient,&#8221; but the certainty of evidence supporting this evaluation is very low, due to the absence of independent studies assessing content validity.</p></sec><sec id="pai70191-sec-0018"><label>3.4.2</label><title>Internal consistency</title><p>Internal consistency was assessed in five studies,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="pai70191-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> with all studies reporting a Cronbach's alpha &gt;0.70. However, studies did not display at least low evidence for sufficient structural validity. Therefore, the internal consistency was rated as &#8220;Indeterminate&#8221; (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>). Regardless, we quantitatively summarized the results for internal consistency (Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref>). CARATkids displayed a meta&#8208;analytical Cronbach alpha of 0.81 (95% CI&#8201;=&#8201;0.79; 0.83) with low heterogeneity (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;23.6%) (Certainty of Evidence: Low).</p></sec><sec id="pai70191-sec-0019"><label>3.4.3</label><title>Reliability</title><p>Reliability was evaluated in four studies,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> all of which presented an ICC&#8201;&gt;&#8201;0.70. Based on this, this psychometric parameter was considered &#8220;Sufficient.&#8221; Meta&#8208;analytical results for reliability revealed high reliability, with an ICC&#8201;=&#8201;0.86 (95% CI&#8201;=&#8201;0.61; 0.96) with severe heterogeneity (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;97.4%) (Certainty of Evidence: Low) (Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref>, Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>).</p></sec><sec id="pai70191-sec-0020"><label>3.4.4</label><title>Measurement error</title><p>Measurement error was assessed in three studies,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> with a low risk of bias. The reported smallest error of measurement of CARATkids was 1.3,<xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> while the minimal clinically important difference was 2.76.<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p></sec><sec id="pai70191-sec-0021"><label>3.4.5</label><title>Construct validity</title><p>Construct (convergent) validity was assessed in seven studies,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>, <xref rid="pai70191-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> but one of them did not report correlation coefficients nor areas under the ROC curve.<xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> We found mostly &#8220;Sufficient&#8221; evidence for construct validity, except for correlations with VAS nose. Certainty of evidence ranged from low to high (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>).</p><p>In quantitative synthesis, CARATkids displayed strong correlations with most instruments, including VAS global (one study<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>), VAS asthma (four studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>), cACT (five studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>), and TNSS (two studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>) (Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref>). Neither EQ&#8208;5D&#8208;Y (one study<xref rid="pai70191-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref>) nor VAS nose (four studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>) yielded a strong correlation with CARATkids (Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref>). Absolute meta&#8208;analytical Spearman coefficients for the correlation between CARATkids and each measurement instrument ranged from 0.37 to 0.71 (Table&#160;<xref rid="pai70191-tbl-0003" ref-type="table">3</xref>). Substantial heterogeneity was observed for VAS asthma (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;57.5%, in leave&#8208;one&#8208;out sensitivity analysis after excluding the study Batmaz 2018: <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;4.9%), cACT (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;67.7%), and TNSS (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;93.0%).</p><p>Four studies reported areas under the ROC curve,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> all of them displaying an area under the ROC curve &#8805;0.70 (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S7</xref>).</p></sec><sec id="pai70191-sec-0022"><label>3.4.6</label><title>Responsiveness</title><p>Five studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> provided evidence for responsiveness (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>). We found &#8220;Sufficient&#8221; responsiveness with VAS nose (four studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>), VAS global (one study<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>) and cACT (five studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>), and &#8220;Inconsistent&#8221; responsiveness with VAS asthma (four studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>) and the TNSS (two studies<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>). Certainty of evidence was moderate to high (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>).</p><p>In quantitative synthesis, CARATkids displayed high responsiveness when compared to changes in the majority of assessed outcome instruments, except for correlation with VAS asthma: 0.49 (95% CI&#8201;=&#8201;0.36; 0.61). For the other PROMs, meta&#8208;analytical correlation coefficients for responsiveness ranged from 0.53 to 0.60 (Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S6</xref>). Substantial heterogeneity was observed for VAS asthma (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;55.9%, in leave&#8208;one&#8208;out sensitivity analysis after excluding the study Amaral 2017: <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;0%), cACT (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;83.5%, in leave&#8208;one&#8208;out sensitivity analysis after excluding the study Batmaz 2018: <italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;0%), and TNSS (<italic toggle="yes">I</italic>
<sup>2</sup>&#8201;=&#8201;48.6%).</p></sec><sec id="pai70191-sec-0023"><label>3.4.7</label><title>Cross&#8208;cultural validity</title><p>No multiple group factor analysis or differential item functioning was performed in cross&#8208;cultural validity studies. Nevertheless, we present the measurement properties per country reported in validation studies in Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S8</xref>. Importantly, this table does not include any Italian studies because they do not report on the measurement properties of interest.<xref rid="pai70191-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="pai70191-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> The properties are consistent throughout the other four countries in which CARATkids has been validated, except for reliability, where there is some heterogeneity.<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref>
</p></sec></sec><sec id="pai70191-sec-0024"><label>3.5</label><title>Interpretability and Feasibility</title><p>Interpretability is summarized in Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S9</xref>. One study reported the percentage of missing items,<xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> which was low (0.3%). One study<xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> provided data on participants achieving minimum (floor score) and maximum (ceiling score) scores, with floor scores ranging from 8.2% to 15.6% and ceiling scores from 0.9% to 1.8%. Feasibility is described in Table&#160;<xref rid="pai70191-supitem-0001" ref-type="supplementary-material">S10</xref>. CARATkids includes 13 questions. The time for its completion was not assessed in any of the included studies. Its use for individual purposes is free and does not require any prior authorization for clinical use.</p></sec></sec><sec sec-type="discussion" id="pai70191-sec-0025"><label>4</label><title>DISCUSSION</title><p>This study represents the first systematic review of measurement properties for a PROM in pediatric asthma and allergic rhinitis in accordance with the recommendations of the COSMIN guidelines.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> We found CARATkids to display good content validity, internal consistency, reliability, construct validity, and responsiveness. These results suggest it is an appropriate instrument for use in the evaluation of asthma and allergic rhinitis control in children aged 6 to 12&#8201;years.</p><p>CARATkids was originally developed in Portuguese, using CARAT<xref rid="pai70191-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> for adults as the base for its preliminary version. Its development was conducted by a panel of 26 specialists in asthma and allergic rhinitis, with diverse and complementary medical specialties.<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> The version obtained in two consensus meetings was submitted to a cognitive test, leading to further modifications after feedback from children and their caregivers. However, the quality of its development was rated as &#8220;Inadequate,&#8221; following COSMIN guidelines, due to the lack of involvement of children and caregivers in PROM development prior to the cognitive interview.<xref rid="pai70191-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>, <xref rid="pai70191-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Importantly, other PROMs<xref rid="pai70191-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref>, <xref rid="pai70191-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="pai70191-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref>, <xref rid="pai70191-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> available for asthma in children have also shown inadequate PROM development. Additionally, among these PROMs, CARATkids was the only PROM undergoing a cognitive interview study, which is important for evaluating comprehensibility and comprehensiveness of a PROM.<xref rid="pai70191-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> This cognitive interview was carried out in a representative sample of the population for which CARATkids was developed.<xref rid="pai70191-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> In addition, considering that the development process was based on an analogous version in clinical use for adults and its widespread clinical application,<xref rid="pai70191-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> we believe that this rating does not interfere with its appropriateness for clinical use.</p><p>Content validity refers to the extent to which an instrument adequately represents the construct it is designed to measure.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> It is widely regarded as the most important measurement property of an instrument. According to the development study<xref rid="pai70191-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> and the independent assessment by two authors, content validity was considered &#8220;Sufficient.&#8221; However, the certainty of evidence was considered to be &#8220;Very low,&#8221; since there are no content validity studies available. Indeed, most asthma PROMs have not had their content validity rigorously assessed.<xref rid="pai70191-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>, <xref rid="pai70191-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p><p>Regarding internal consistency, for it to be considered &#8220;Sufficient,&#8221; Cronbach alpha must be &#8805;0.7 and structural validity must be at least &#8220;Sufficient&#8221; with low evidence.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> We found a meta&#8208;analytical Cronbach alpha of 0.82 with low heterogeneity, suggesting good internal consistency. None of the studies, however, assessed its structural validity (i.e., none of the published studies carried out a factor analysis, principal component analysis, Rasch analysis, or item response theory analysis). Therefore, internal consistency was rated &#8220;Indeterminate.&#8221;</p><p>CARATkids displayed high reliability, albeit with substantial heterogeneity. A few factors might be accountable for that. First, one of the studies<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> lacked a clearly defined interval between visits, ranging from 2 to 49&#8201;weeks, while other studies evaluating reliability presented much shorter ranges: either 3 to 6&#8201;weeks<xref rid="pai70191-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> or 4 to 6&#8201;weeks apart.<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Additionally, the same study collected data in three different visits, while the other applied the questionnaire in two visits only.</p><p>There is no comparable gold standard assessing the control of asthma and allergic rhinitis. Therefore, we considered the comparisons between CARATkids and other validated PROMs to be evidence for construct validity (namely convergent validity), as construct validity reflects the degree to which the scores of a PROM are consistent with a priori hypotheses.<xref rid="pai70191-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>, <xref rid="pai70191-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Except for VAS nose and EQ&#8208;5D&#8208;Y, we observed a strong correlation between CARATkids and the outcome measurement instruments to which it was compared, namely VAS global, VAS asthma, cACT, and the TNSS. Regarding EQ&#8208;5D&#8208;Y, a weaker correlation was expected, since this tool does not measure asthma or allergic rhinitis control, but rather health&#8208;related quality of life, which is a related but dissimilar construct.<xref rid="pai70191-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> Importantly, substantial heterogeneity was found in the comparisons with VAS asthma, cACT, and TNSS.</p><p>Our meta&#8208;analysis pointed to good responsiveness when compared with VAS global, VAS nose, cACT, and TNSS, but important heterogeneity was observed for cACT. Given CARATkids strong internal consistency and validity properties, it is possible that its growing use could yield more evidence for responsiveness in future studies.</p><p>Regarding cross&#8208;cultural validity, CARATkids has been translated, culturally adapted, and clinically validated for Brazilian Portuguese,<xref rid="pai70191-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Dutch,<xref rid="pai70191-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and Turkish,<xref rid="pai70191-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> but no results on measurement invariance were reported, precluding the assessment of cross&#8208;cultural validity. Nevertheless, we found consistent results reported in validation studies performed in different countries.</p><p>Regarding interpretability and feasibility, CARATkids was reported to be easy to understand by both patients and physicians, requiring only basic literacy and commonly available resources. It is also freely available for clinical use, supporting its applicability for assessing asthma and allergic rhinitis control in routine care.</p><p>Finally, we highlight that a recent study validated the electronic version of CARATKids against the gold standard paper&#8208;based version, with the authors finding comparable internal consistency and reliability of the electronic version, in addition to a strong correlation between the electronic and paper versions, reflecting high construct validity.<xref rid="pai70191-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> The validation of an electronic version together with this synthesis of measurement properties puts this PROM well positioned to be used in clinical studies.</p><p>This systematic review has some limitations worth noting. Firstly, the absence of a gold standard for the assessment of allergic rhinitis and asthma control precluded us from assessing criterion validity. We did, however, assess the construct validity (convergent validity) in comparison with other PROMs available for allergic rhinitis and asthma. Secondly, substantial heterogeneity was found for most analyses on construct validity and responsiveness. In many cases, however, heterogeneity decreased in leave&#8208;one&#8208;out sensitivity analysis without impacting the main conclusions. Third, the small number of included primary studies precluded us from following additional approaches for identification of sources of heterogeneity (such as meta&#8208;regression). Besides that, it was not possible to assess structural validity, since none of the included studies evaluated this property. Finally, there is insufficient evidence on the quality of other PROMs used in allergic rhinitis or asthma, including on their development and content validity.<xref rid="pai70191-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Therefore, there is a need for further COSMIN&#8208;based systematic reviews with meta&#8208;analysis on other PROMs used in asthma and/or allergic rhinitis for pediatric patients.</p><p>This study presents important strengths. There have been previous systematic reviews of PROMs for allergic rhinitis or asthma in a pediatric population; however, they either did not assess the development quality of the PROMs, did not follow COSMIN recommendations,<xref rid="pai70191-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="pai70191-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> or did not perform a meta&#8208;analysis of measurement properties.<xref rid="pai70191-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref> The evidence obtained from this systematic review supports the use of CARATkids in clinical practice. Additionally, we performed a thorough literature search, including manually searching Google Scholar and screening references of included studies to minimize the risk of missing relevant publications. Finally, we were able to perform a meta&#8208;analysis of most measurement properties.</p><p>In conclusion, this is the first systematic review with meta&#8208;analysis to evaluate and summarize the measurement properties of a pediatric PROM designed for assessing the control of allergic rhinitis and asthma simultaneously. The findings indicate that CARATkids presents good content validity. Strong internal consistency and good reliability were also observed, albeit with low certainty of evidence. Responsiveness and construct validity also showed good results, with at least moderate evidence for most correlations. Overall, these findings support the suitability of CARATkids for assessment of asthma and allergic rhinitis in children from 6 to 12&#8201;years who present both diseases simultaneously. Future studies may aim to further validate the content and structural validity of CARATkids. Furthermore, additional systematic reviews of other PROMs used in the assessment of pediatric allergic rhinitis or asthma would support more comprehensive comparisons across available instruments.</p></sec><sec id="pai70191-sec-0027"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Hadla Sami El Didi:</bold> Data curation; formal analysis; investigation; visualization; writing &#8211; original draft; writing &#8211; review and editing. <bold>Ana Margarida Pereira:</bold> Writing &#8211; review and editing. <bold>Cristina J&#225;come:</bold> Writing &#8211; review and editing. <bold>Rita Amaral:</bold> Writing &#8211; review and editing. <bold>Gustavo F. Wandalsen:</bold> Writing &#8211; review and editing. <bold>Joyce Emons:</bold> Writing &#8211; review and editing. <bold>Stefania La Grutta:</bold> Writing &#8211; review and editing. <bold>Giovanna Cilluffo:</bold> Writing &#8211; review and editing. <bold>Sehra Birg&#252;l Batmaz:</bold> Writing &#8211; review and editing. <bold>Daniela Linhares:</bold> Writing &#8211; review and editing. <bold>Dirceu Sole:</bold> Writing &#8211; review and editing. <bold>Bernardo Sousa&#8208;Pinto:</bold> Writing &#8211; original draft. <bold>Jo&#227;o Almeida Fonseca:</bold> Supervision; writing &#8211; review and editing. <bold>Rafael Jos&#233; Vieira:</bold> Conceptualization; data curation; formal analysis; investigation; supervision; writing &#8211; original draft; writing &#8211; review and editing.</p></sec><sec sec-type="COI-statement" id="pai70191-sec-0026"><title>CONFLICT OF INTEREST STATEMENT</title><p>Ana Margarida Pereira, Cristina J&#225;come, Rita Amaral, Gustavo F. Wandalsen, Joyce Emons, Stefania La Grutta, Giovanna Cilluffo, Sehra Birg&#252;l Batmaz, Daniela Linhares, Dirceu Sole, and Jo&#227;o Almeida Fonseca were involved in the original studies of the development, validation, and/or mobile phone adaptation of CARATkids.</p></sec><sec sec-type="peer-review" id="pai70191-sec-0029"><title>PEER REVIEW</title><p>The peer review history for this article is available at <ext-link xlink:href="https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/pai.70191" ext-link-type="uri">https://www.webofscience.com/api/gateway/wos/peer&#8208;review/10.1111/pai.70191</ext-link>.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pai70191-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Data S1
</p></caption><media xlink:href="PAI-36-e70191-s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="pai70191-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
Data S2
</p></caption><media xlink:href="PAI-36-e70191-s001.xlsx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="pai70191-sec-29"><title>ACKNOWLEDGMENT</title><p>Wiley and FCT/b&#8208;on have an agreement to cover the cost of your open access publishing. Please note: FCT/b&#8208;on strongly encourages you to apply a CC BY license to your article as this will amplify the article visibility and knowledge advancement, while retaining full credit of your authorship.</p></ack><ref-list content-type="cited-references" id="pai70191-bibl-0001"><title>REFERENCES</title><ref id="pai70191-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="pai70191-cit-0001"><string-name name-style="western"><surname>Churruca</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pomare</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ellis</surname><given-names>LA</given-names></string-name>, et&#160;al. <article-title>Patient&#8208;reported outcome measures (PROMs): a review of generic and condition&#8208;specific measures and a discussion of trends and issues</article-title>. <source>Health Expect</source>. <year>2021</year>;<volume>24</volume>:<fpage>1015</fpage>&#8208;<lpage>1024</lpage>.<pub-id pub-id-type="pmid">33949755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hex.13254</pub-id><pub-id pub-id-type="pmcid">PMC8369118</pub-id></mixed-citation></ref><ref id="pai70191-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="pai70191-cit-0002"><string-name name-style="western"><surname>Carrozzino</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Patierno</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guidi</surname><given-names>J</given-names></string-name>, et&#160;al. <article-title>Clinimetric criteria for patient&#8208;reported outcome measures</article-title>. <source>Psychother Psychosom</source>. <year>2021</year>;<volume>90</volume>:<fpage>222</fpage>&#8208;<lpage>232</lpage>.<pub-id pub-id-type="pmid">34038901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000516599</pub-id></mixed-citation></ref><ref id="pai70191-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="pai70191-cit-0003"><string-name name-style="western"><surname>McGee</surname><given-names>RG</given-names></string-name>. <article-title>How to include patient&#8208;reported outcome measures in clinical trials</article-title>. <source>Curr Osteoporos Rep</source>. <year>2020</year>;<volume>18</volume>:<fpage>480</fpage>&#8208;<lpage>485</lpage>.<pub-id pub-id-type="pmid">32757118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11914-020-00611-5</pub-id></mixed-citation></ref><ref id="pai70191-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="pai70191-cit-0004"><string-name name-style="western"><surname>Soyiri</surname><given-names>IN</given-names></string-name>, <string-name name-style="western"><surname>Nwaru</surname><given-names>BI</given-names></string-name>, <string-name name-style="western"><surname>Sheikh</surname><given-names>A</given-names></string-name>. <article-title>Patient&#8208;reported outcome measures for allergy and asthma in children</article-title>. <source>Pediatr Allergy Immunol</source>. <year>2016</year>;<volume>27</volume>:<fpage>779</fpage>&#8208;<lpage>783</lpage>.<pub-id pub-id-type="pmid">27289076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pai.12603</pub-id></mixed-citation></ref><ref id="pai70191-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="pai70191-cit-0005"><string-name name-style="western"><surname>Zuberbier</surname><given-names>T</given-names></string-name>. <article-title>Another PROM that children as well as adults can use to monitor their chronic disease</article-title>. <source>J Allergy Clin Immunol Pract</source>. <year>2022</year>;<volume>10</volume>:<fpage>3299</fpage>.<pub-id pub-id-type="pmid">36496215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2022.09.018</pub-id></mixed-citation></ref><ref id="pai70191-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="pai70191-cit-0006"><string-name name-style="western"><surname>Chu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Kappel</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Akel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Press</surname><given-names>VG</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Volerman</surname><given-names>A</given-names></string-name>. <article-title>Validity of the childhood asthma control test in diverse populations: a systematic review</article-title>. <source>Pediatr Pulmonol</source>. <year>2023</year>;<volume>58</volume>:<fpage>1322</fpage>&#8208;<lpage>1336</lpage>.<pub-id pub-id-type="pmid">36718492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.26342</pub-id><pub-id pub-id-type="pmcid">PMC10121871</pub-id></mixed-citation></ref><ref id="pai70191-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="pai70191-cit-0007"><string-name name-style="western"><surname>Juniper</surname><given-names>EF</given-names></string-name>, <string-name name-style="western"><surname>Guyatt</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Feeny</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Ferrie</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Griffith</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Townsend</surname><given-names>M</given-names></string-name>. <article-title>Measuring quality of life in children with asthma</article-title>. <source>Qual Life Res</source>. <year>1996</year>;<volume>5</volume>:<fpage>35</fpage>&#8208;<lpage>46</lpage>.<pub-id pub-id-type="pmid">8901365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00435967</pub-id></mixed-citation></ref><ref id="pai70191-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="pai70191-cit-0008"><string-name name-style="western"><surname>Worth</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hammersley</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Knibb</surname><given-names>R</given-names></string-name>, et&#160;al. <article-title>Patient&#8208;reported outcome measures for asthma: a systematic review</article-title>. <source>NPJ Prim Care Respir Med</source>. <year>2014</year>;<volume>24</volume>:<fpage>14020</fpage>.<pub-id pub-id-type="pmid">24964767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/npjpcrm.2014.20</pub-id><pub-id pub-id-type="pmcid">PMC4373322</pub-id></mixed-citation></ref><ref id="pai70191-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="pai70191-cit-0009"><string-name name-style="western"><surname>Skinner</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Diette</surname><given-names>GB</given-names></string-name>, <string-name name-style="western"><surname>Algatt&#8208;Bergstrom</surname><given-names>PJ</given-names></string-name>, et&#160;al. <article-title>The asthma therapy assessment questionnaire (ATAQ) for children and adolescents</article-title>. <source>Dis Manag</source>. <year>2004</year>;<volume>7</volume>:<fpage>305</fpage>&#8208;<lpage>313</lpage>.<pub-id pub-id-type="pmid">15671787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/dis.2004.7.305</pub-id></mixed-citation></ref><ref id="pai70191-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="pai70191-cit-0010"><string-name name-style="western"><surname>Batmaz</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Tokg&#246;z</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Fonseca</surname><given-names>JA</given-names></string-name>. <article-title>Validity and the reliability of the Turkish version of the control of allergic rhinitis and asthma test for children (CARATKids)</article-title>. <source>J Asthma</source>. <year>2019</year>;<volume>56</volume>:<fpage>1231</fpage>&#8208;<lpage>1238</lpage>.<pub-id pub-id-type="pmid">30407087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/02770903.2018.1534969</pub-id></mixed-citation></ref><ref id="pai70191-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="pai70191-cit-0011"><string-name name-style="western"><surname>Borrego</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Fonseca</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Pinto</surname><given-names>VR</given-names></string-name>, <string-name name-style="western"><surname>Linhares</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Morais&#8208;Almeida</surname><given-names>M</given-names></string-name>. <article-title>Development process and cognitive testing of CARATkids &#8208; control of allergic rhinitis and asthma test for children</article-title>. <source>BMC Pediatr</source>. <year>2014</year>;<volume>14</volume>:<elocation-id>34</elocation-id>.<pub-id pub-id-type="pmid">24502226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2431-14-34</pub-id><pub-id pub-id-type="pmcid">PMC3922506</pub-id></mixed-citation></ref><ref id="pai70191-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="pai70191-cit-0012"><string-name name-style="western"><surname>Bousquet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sch&#252;nemann</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Togias</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Next&#8208;generation allergic rhinitis and its impact on asthma (ARIA) guidelines for allergic rhinitis based on grading of recommendations assessment, development and evaluation (GRADE) and real&#8208;world evidence</article-title>. <source>J Allergy Clin Immunol</source>. <year>2020</year>;<volume>145</volume>:<fpage>70</fpage>&#8208;<lpage>80.e3</lpage>.<pub-id pub-id-type="pmid">31627910</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2019.06.049</pub-id></mixed-citation></ref><ref id="pai70191-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="pai70191-cit-0013"><string-name name-style="western"><surname>Vieira</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Sousa&#8208;Pinto</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Cardoso&#8208;Fernandes</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>Control of allergic rhinitis and asthma test: a systematic review of measurement properties and COSMIN analysis</article-title>. <source>Clin Transl Allergy</source>. <year>2022</year>;<volume>12</volume>:<elocation-id>e12194</elocation-id>.<pub-id pub-id-type="pmid">36178185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/clt2.12194</pub-id><pub-id pub-id-type="pmcid">PMC9510765</pub-id></mixed-citation></ref><ref id="pai70191-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="pai70191-cit-0014"><string-name name-style="western"><surname>Linhares</surname><given-names>DV</given-names></string-name>, <string-name name-style="western"><surname>da Fonseca</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Borrego</surname><given-names>LM</given-names></string-name>, et&#160;al. <article-title>Validation of control of allergic rhinitis and asthma test for children (CARATKids)&#8208;&#8208;a prospective multicenter study</article-title>. <source>Pediatr Allergy Immunol</source>. <year>2014</year>;<volume>25</volume>:<fpage>173</fpage>&#8208;<lpage>179</lpage>.<pub-id pub-id-type="pmid">24628568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pai.12218</pub-id></mixed-citation></ref><ref id="pai70191-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="pai70191-cit-0015"><string-name name-style="western"><surname>Amaral</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Carneiro</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Wandalsen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fonseca</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Sole</surname><given-names>D</given-names></string-name>. <article-title>Control of allergic rhinitis and asthma test for children (CARATKids): validation in Brazil and cutoff values</article-title>. <source>Ann Allergy Asthma Immunol</source>. <year>2017</year>;<volume>118</volume>:<fpage>551</fpage>&#8208;<lpage>556</lpage>.<pub-id pub-id-type="pmid">28366584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.anai.2017.02.007</pub-id></mixed-citation></ref><ref id="pai70191-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="pai70191-cit-0016"><string-name name-style="western"><surname>Cilluffo</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fasola</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ferrante</surname><given-names>G</given-names></string-name>, et&#160;al. <article-title>Overrating classifier performance in ROC analysis in the absence of a test set: evidence from simulation and Italian CARATkids validation</article-title>. <source>Methods Inf Med</source>. <year>2019</year>;<volume>58</volume>:<fpage>e27</fpage>&#8208;<lpage>e42</lpage>.<pub-id pub-id-type="pmid">31746447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0039-1693732</pub-id></mixed-citation></ref><ref id="pai70191-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="pai70191-cit-0017"><string-name name-style="western"><surname>Tosca</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Del Barba</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Licari</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ciprandi</surname><given-names>G</given-names></string-name>, <collab collab-type="authors">Asthma And Rhinitis Control Study Group</collab>
. <article-title>The measurement of asthma and allergic rhinitis control in children and adolescents</article-title>. <source>Children (Basel)</source>. <year>2020</year>;<volume>7</volume>:<fpage>43</fpage>.<pub-id pub-id-type="pmid">32392738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/children7050043</pub-id><pub-id pub-id-type="pmcid">PMC7278597</pub-id></mixed-citation></ref><ref id="pai70191-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="pai70191-cit-0018"><string-name name-style="western"><surname>Emons</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Flokstra</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>de Jong</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Use of the control of allergic rhinitis and asthma test (CARATkids) in children and adolescents: validation in Dutch</article-title>. <source>Pediatr Allergy Immunol</source>. <year>2017</year>;<volume>28</volume>:<fpage>185</fpage>&#8208;<lpage>190</lpage>.<pub-id pub-id-type="pmid">27801950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pai.12678</pub-id></mixed-citation></ref><ref id="pai70191-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="pai70191-cit-0019"><string-name name-style="western"><surname>Prinsen</surname><given-names>CAC</given-names></string-name>, <string-name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Bouter</surname><given-names>LM</given-names></string-name>, et&#160;al. <article-title>COSMIN guideline for systematic reviews of patient&#8208;reported outcome measures</article-title>. <source>Qual Life Res</source>. <year>2018</year>;<volume>27</volume>:<fpage>1147</fpage>&#8208;<lpage>1157</lpage>.<pub-id pub-id-type="pmid">29435801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11136-018-1798-3</pub-id><pub-id pub-id-type="pmcid">PMC5891568</pub-id></mixed-citation></ref><ref id="pai70191-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="pai70191-cit-0020"><string-name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>de Vet</surname><given-names>HCW</given-names></string-name>, <string-name name-style="western"><surname>Prinsen</surname><given-names>CAC</given-names></string-name>, et&#160;al. <article-title>COSMIN risk of bias checklist for systematic reviews of patient&#8208;reported outcome measures</article-title>. <source>Qual Life Res</source>. <year>2018</year>;<volume>27</volume>:<fpage>1171</fpage>&#8208;<lpage>1179</lpage>.<pub-id pub-id-type="pmid">29260445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11136-017-1765-4</pub-id><pub-id pub-id-type="pmcid">PMC5891552</pub-id></mixed-citation></ref><ref id="pai70191-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="pai70191-cit-0021"><string-name name-style="western"><surname>Terwee</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Prinsen</surname><given-names>CAC</given-names></string-name>, <string-name name-style="western"><surname>Chiarotto</surname><given-names>A</given-names></string-name>, et&#160;al. <article-title>COSMIN methodology for evaluating the content validity of patient&#8208;reported outcome measures: a Delphi study</article-title>. <source>Qual Life Res</source>. <year>2018</year>;<volume>27</volume>:<fpage>1159</fpage>&#8208;<lpage>1170</lpage>.<pub-id pub-id-type="pmid">29550964</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11136-018-1829-0</pub-id><pub-id pub-id-type="pmcid">PMC5891557</pub-id></mixed-citation></ref><ref id="pai70191-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="pai70191-cit-0022"><string-name name-style="western"><surname>Page</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>McKenzie</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Bossuyt</surname><given-names>PM</given-names></string-name>, et&#160;al. <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>BMJ</source>. <year>2021</year>;<volume>372</volume>:<elocation-id>n71</elocation-id>.<pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></mixed-citation></ref><ref id="pai70191-bib-0023"><label>23</label><mixed-citation publication-type="book" id="pai70191-cit-0023"><string-name name-style="western"><surname>Terwee</surname><given-names>CB</given-names></string-name>, <string-name name-style="western"><surname>Prinsen</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Chiarotto</surname><given-names>A</given-names></string-name>. <source>COSMIN Methodology for Assessing the Content Validity of PROMs &#8211; User Manual</source>. <publisher-name>VU University Medical Center</publisher-name>; <year>2018</year>.</mixed-citation></ref><ref id="pai70191-bib-0024"><label>24</label><mixed-citation publication-type="book" id="pai70191-cit-0024"><string-name name-style="western"><surname>De Vet</surname><given-names>HCTC</given-names></string-name>, <string-name name-style="western"><surname>Mokkink</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Knol</surname><given-names>DL</given-names></string-name>. <source>Measurement in Medicine: A Practical Guide</source>. <publisher-name>Cambridge University Press</publisher-name>; <year>2011</year>.</mixed-citation></ref><ref id="pai70191-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="pai70191-cit-0025"><string-name name-style="western"><surname>Piggott</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Morgan</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Cuello&#8208;Garcia</surname><given-names>CA</given-names></string-name>, et&#160;al. <article-title>Grading of recommendations assessment, development, and evaluations (GRADE) notes: extremely serious, GRADE's terminology for rating down by three levels</article-title>. <source>J Clin Epidemiol</source>. <year>2020</year>;<volume>120</volume>:<fpage>116</fpage>&#8208;<lpage>120</lpage>.<pub-id pub-id-type="pmid">31866468</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2019.11.019</pub-id></mixed-citation></ref><ref id="pai70191-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="pai70191-cit-0026"><string-name name-style="western"><surname>Bonett</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>TA</given-names></string-name>. <article-title>Sample size requirements for estimating pearson, kendall and spearman correlations</article-title>. <source>Psychometrika</source>. <year>2000</year>;<volume>65</volume>:<fpage>23</fpage>&#8208;<lpage>28</lpage>.</mixed-citation></ref><ref id="pai70191-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="pai70191-cit-0027"><string-name name-style="western"><surname>Feldt</surname><given-names>LS</given-names></string-name>, <string-name name-style="western"><surname>Woodruff</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Salih</surname><given-names>FA</given-names></string-name>. <article-title>Statistical inference for coefficient alpha</article-title>. <source>Appl Psychol Measur</source>. <year>1987</year>;<volume>11</volume>:<fpage>93</fpage>&#8208;<lpage>103</lpage>.</mixed-citation></ref><ref id="pai70191-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="pai70191-cit-0028"><string-name name-style="western"><surname>Borrego</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Fonseca</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pereira</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Pinto</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Linhares</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Morais&#8208;Almeida</surname><given-names>M</given-names></string-name>. <article-title>Desenvolvimento do question&#225;rio CARATkids</article-title>. <source>Rev Port Imunoalergologia</source>. <year>2014</year>;<volume>22</volume>(<issue>3</issue>):<fpage>183</fpage>&#8208;<lpage>193</lpage>.</mixed-citation></ref><ref id="pai70191-bib-0029"><label>29</label><mixed-citation publication-type="miscellaneous" id="pai70191-cit-0029"><collab collab-type="authors">Resende, CSDS</collab>
. <article-title>Quality of life and control of asthma and/or allergic rhinitis in children: Correlative study with CARAT Kids and ED&#8208;5D&#8208;Y</article-title>. (QoLARy). In: Santiago, LMdMS, ed.</mixed-citation></ref><ref id="pai70191-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="pai70191-cit-0030"><string-name name-style="western"><surname>Abreu da Mata</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Pais&#8208;Cunha</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Ferraz</surname><given-names>S</given-names></string-name>, et&#160;al. <article-title>Validation and acceptability of the mobile app version of the control of allergic rhinitis and asthma test for children (CARATKids): a cross&#8208;sectional study</article-title>. <source>JMIR Pediatr Parent</source>. <year>2025</year>;<volume>8</volume>:<elocation-id>e73531</elocation-id>.<pub-id pub-id-type="pmid">40743508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/73531</pub-id><pub-id pub-id-type="pmcid">PMC12313081</pub-id></mixed-citation></ref><ref id="pai70191-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="pai70191-cit-0031"><string-name name-style="western"><surname>Leidy</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Vernon</surname><given-names>M</given-names></string-name>. <article-title>Perspectives on patient&#8208;reported outcomes: content validity and qualitative research in a changing clinical trial environment</article-title>. <source>PharmacoEconomics</source>. <year>2008</year>;<volume>26</volume>:<fpage>363</fpage>&#8208;<lpage>370</lpage>.<pub-id pub-id-type="pmid">18429654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00019053-200826050-00002</pub-id></mixed-citation></ref><ref id="pai70191-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="pai70191-cit-0032"><string-name name-style="western"><surname>Vogt</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>DW</given-names></string-name>, <string-name name-style="western"><surname>King</surname><given-names>LA</given-names></string-name>. <article-title>Focus groups in psychological assessment: enhancing content validity by consulting members of the target population</article-title>. <source>Psychol Assess</source>. <year>2004</year>;<volume>16</volume>:<fpage>231</fpage>&#8208;<lpage>243</lpage>.<pub-id pub-id-type="pmid">15456379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/1040-3590.16.3.231</pub-id></mixed-citation></ref><ref id="pai70191-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="pai70191-cit-0033"><string-name name-style="western"><surname>Liu</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Zeiger</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sorkness</surname><given-names>C</given-names></string-name>, et&#160;al. <article-title>Development and cross&#8208;sectional validation of the childhood asthma control test</article-title>. <source>J Allergy Clin Immunol</source>. <year>2007</year>;<volume>119</volume>:<fpage>817</fpage>&#8208;<lpage>825</lpage>.<pub-id pub-id-type="pmid">17353040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2006.12.662</pub-id></mixed-citation></ref><ref id="pai70191-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="pai70191-cit-0034"><string-name name-style="western"><surname>Christie</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>French</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sowden</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>West</surname><given-names>A</given-names></string-name>. <article-title>Development of child&#8208;centered disease&#8208;specific questionnaires for living with asthma</article-title>. <source>Psychosom Med</source>. <year>1993</year>;<volume>55</volume>:<fpage>541</fpage>&#8208;<lpage>548</lpage>.<pub-id pub-id-type="pmid">8310115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006842-199311000-00010</pub-id></mixed-citation></ref><ref id="pai70191-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="pai70191-cit-0035"><string-name name-style="western"><surname>Christie</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>French</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Weatherstone</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>West</surname><given-names>A</given-names></string-name>, <collab collab-type="authors">Applied Psychology Research Group</collab>
. <article-title>The patients' perceptions of chronic disease and its management: psychosomatics, holism and quality of life in contemporary management of childhood asthma</article-title>. <source>Psychother Psychosom</source>. <year>1991</year>;<volume>56</volume>:<fpage>197</fpage>&#8208;<lpage>203</lpage>.<pub-id pub-id-type="pmid">1801041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000288556</pub-id></mixed-citation></ref><ref id="pai70191-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="pai70191-cit-0036"><string-name name-style="western"><surname>Murphy</surname><given-names>KR</given-names></string-name>, <string-name name-style="western"><surname>Zeiger</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Kosinski</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Test for respiratory and asthma control in kids (TRACK): a caregiver&#8208;completed questionnaire for preschool&#8208;aged children</article-title>. <source>J Allergy Clin Immunol</source>. <year>2009</year>;<volume>123</volume>:<fpage>833</fpage>&#8208;<lpage>839</lpage>.<pub-id pub-id-type="pmid">19348922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2009.01.058</pub-id></mixed-citation></ref><ref id="pai70191-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="pai70191-cit-0037"><string-name name-style="western"><surname>Cloutier</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Schatz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Castro</surname><given-names>M</given-names></string-name>, et&#160;al. <article-title>Asthma outcomes: composite scores of asthma control</article-title>. <source>J Allergy Clin Immunol</source>. <year>2012</year>;<volume>129</volume>:<fpage>S24</fpage>&#8208;<lpage>S33</lpage>.<pub-id pub-id-type="pmid">22386507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2011.12.980</pub-id><pub-id pub-id-type="pmcid">PMC4269334</pub-id></mixed-citation></ref><ref id="pai70191-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="pai70191-cit-0038"><string-name name-style="western"><surname>Calder&#243;n</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Casale</surname><given-names>TB</given-names></string-name>, <string-name name-style="western"><surname>Demoly</surname><given-names>P</given-names></string-name>. <article-title>Validation of patient&#8208;reported outcomes for clinical trials in allergic rhinitis: a systematic review</article-title>. <source>J Allergy Clin Immunol Pract</source>. <year>2019</year>;<volume>7</volume>:<fpage>1450</fpage>&#8208;<lpage>1461</lpage>.<pub-id pub-id-type="pmid">30797777</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2019.01.015</pub-id></mixed-citation></ref><ref id="pai70191-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="pai70191-cit-0039"><string-name name-style="western"><surname>Sullivan</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Ghushchyan</surname><given-names>VH</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Globe</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Bender</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Magid</surname><given-names>DJ</given-names></string-name>. <article-title>Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes</article-title>. <source>Qual Life Res</source>. <year>2016</year>;<volume>25</volume>:<fpage>3017</fpage>&#8208;<lpage>3026</lpage>.<pub-id pub-id-type="pmid">27387417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11136-016-1357-8</pub-id></mixed-citation></ref><ref id="pai70191-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="pai70191-cit-0040"><string-name name-style="western"><surname>Bousema</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bohnen</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Bindels</surname><given-names>PJE</given-names></string-name>, <string-name name-style="western"><surname>Elshout</surname><given-names>G</given-names></string-name>. <article-title>A systematic review of questionnaires measuring asthma control in children in a primary care population</article-title>. <source>NPJ Prim Care Respir Med</source>. <year>2023</year>;<volume>33</volume>:<fpage>25</fpage>.<pub-id pub-id-type="pmid">37433825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41533-023-00344-9</pub-id><pub-id pub-id-type="pmcid">PMC10336001</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>